24
19
1
49
2
2
2c
1b
1d
18
79
38
1d
2 29
1d
25
38
Katrina Armstrong, MD, MSCE
5eAdjunct Professor of Medicine (General Internal Medicine)
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
44
4
3
3
1d
44
Department of Medicine
26 Massachusetts General Hospital
2c 55 Fruit Street
Boston, MA 02114
26
26 Massachusetts General Hospital
2c 55 Fruit Street
Boston, MA 02114
2c
Office: 6177268447
30
97
30
Email:
karmstro@mail.med.upenn.edu
12
karmstro@mail.med.upenn.edu
18
Publications
23 a
3
2
29
4
b
1f
23 a
13
Education:
21 9 B.A. 19 (Architecture) c
28 Yale University, 1986.
21 9 M.D. 15 (Medicine) c
31 Johns Hopkins University, 1991.
21 d M.S.C.E. 22 (Clinical Epidemiology) c
33 University of Pennsylvania, 1998.
c
3
3
21
21 9 B.A. 19 (Architecture) c
28 Yale University, 1986.
21 9 M.D. 15 (Medicine) c
31 Johns Hopkins University, 1991.
21 d M.S.C.E. 22 (Clinical Epidemiology) c
33 University of Pennsylvania, 1998.
c
1f
Post-Graduate Training
24 57 Resident in Internal Medicine, The Johns Hopkins Hospital, 1991-1994.
24 60 Chief Resident, Department of Medicine, The Johns Hopkins Hospital, 1995-1996.
24 88 Primary Care Physician Scientist Fellow, Division of General Internal Medicine, University of Pennsylvania, 1996-1998.
c
3
25
24 57 Resident in Internal Medicine, The Johns Hopkins Hospital, 1991-1994.
24 60 Chief Resident, Department of Medicine, The Johns Hopkins Hospital, 1995-1996.
24 88 Primary Care Physician Scientist Fellow, Division of General Internal Medicine, University of Pennsylvania, 1996-1998.
c
17
Certifications
28 3c American Board of Internal Medicine, 2014.
c
3
8a
Permanent link28 3c American Board of Internal Medicine, 2014.
c
2 29
21
1e
1d
24
6a
1a 29
27
Description of Clinical Expertise
54 medical decision making, genetic testing for breast cancer (BRCA1/2)1a 29
23
fc Peters N, Rose A, Armstrong K, : The association between race and attitudes about predictive genetic testing Cancer Epidemiology, Biomarkers and Prevention 13: 361--365, 2004.
119 Armstrong K, Weber BL, Asch DA : Life Insurance Purchasing by Women at Increased Risk for Breast Cancer: Is Adverse Selection a Plausible Threat? American Journal of Medical Genetics 3(120A): 359-364, 2003.
d3 Moran S, Glazier G, Armstrong K: Women Smokers Perceptions of smoking related health risks. Journal of Women's Health 4(2): 363-371, 2003.
123 Armstrong K, Weber B, Stofer J, Calzone K, Putt M, Coyne J, Schwartz JS: Early use of clinical BRCA 1/2 testing: Associations with race and breast cancer risk. American Journal of Medical Genetics 117: 154-160, 2003.
f7 Moran S, Thorndike AN, Armstrong K, Rignotti NA: Physicians missed opportunities to address tobacco use during prenatal care. Nicotine and Tobacco Research 5: 363-368, 2003.
123 Coyne JC, Kruss L, Racioppo M, Calzone KA, Armstrong K: What do ratings of cancer specific distress mean among women at high risk of breast and ovarian cancer. American Journal of Medical Ethics 3(116): 222-228, 2003.
fe Randall TC, Armstrong K: Differences in treatment and outcome between african american and caucasian women with endometrial cancer. Journal of Clinical Oncology 21: 4200-4206, 2003.
fe Armstrong K, Schwartz JS, FitzGerald G: Effect of framing as gain vs. loss on hypothetical treatment choices: survival and mortality curves. Medical Decision Making 21: 76-83, 2002.
135 Cox M, Schwartz S, Metlay J, Armstrong K, Shea J. : Third Annual Meeting of the Undergraduate Medical Education for the 21st Century (UME-21) Project: Teaching the foundations of population-based medicine. AAMC UME Meeting March 2001.
2c
7
1d
1f
Selected Publications
12b Armstrong K, Schwartz JS, Randall TC, Rubin SR, Weber BL: Hormone replacement therapy and life expectancy after prophylactic oophorectomy and in women with BRCA 1/2 mutations. Journal of Clinical Oncology 22: 1045-1054, 2004.fc Peters N, Rose A, Armstrong K, : The association between race and attitudes about predictive genetic testing Cancer Epidemiology, Biomarkers and Prevention 13: 361--365, 2004.
119 Armstrong K, Weber BL, Asch DA : Life Insurance Purchasing by Women at Increased Risk for Breast Cancer: Is Adverse Selection a Plausible Threat? American Journal of Medical Genetics 3(120A): 359-364, 2003.
d3 Moran S, Glazier G, Armstrong K: Women Smokers Perceptions of smoking related health risks. Journal of Women's Health 4(2): 363-371, 2003.
123 Armstrong K, Weber B, Stofer J, Calzone K, Putt M, Coyne J, Schwartz JS: Early use of clinical BRCA 1/2 testing: Associations with race and breast cancer risk. American Journal of Medical Genetics 117: 154-160, 2003.
f7 Moran S, Thorndike AN, Armstrong K, Rignotti NA: Physicians missed opportunities to address tobacco use during prenatal care. Nicotine and Tobacco Research 5: 363-368, 2003.
123 Coyne JC, Kruss L, Racioppo M, Calzone KA, Armstrong K: What do ratings of cancer specific distress mean among women at high risk of breast and ovarian cancer. American Journal of Medical Ethics 3(116): 222-228, 2003.
fe Randall TC, Armstrong K: Differences in treatment and outcome between african american and caucasian women with endometrial cancer. Journal of Clinical Oncology 21: 4200-4206, 2003.
fe Armstrong K, Schwartz JS, FitzGerald G: Effect of framing as gain vs. loss on hypothetical treatment choices: survival and mortality curves. Medical Decision Making 21: 76-83, 2002.
135 Cox M, Schwartz S, Metlay J, Armstrong K, Shea J. : Third Annual Meeting of the Undergraduate Medical Education for the 21st Century (UME-21) Project: Teaching the foundations of population-based medicine. AAMC UME Meeting March 2001.
2c
44
23
Back to Top
1b
1d
18